GLP-1 Adherence: Why People Stop and How to Stay on Track (October 2026)

01 · The core answer

What GLP-1 adherence means and why it matters

GLP-1 adherence is how closely you follow your prescribed plan: the right dose, on the same day each week, with the diet and activity changes that go alongside it. It also covers staying in touch with your prescriber for reviews. Mounjaro is a prescription-only medicine used alongside a reduced-calorie diet and increased physical activity, and individual results vary.

Adherence matters because the medicine only works while it is in your system. Tirzepatide is a once-weekly injection that activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ A missed routine, a stalled dose or an abrupt stop changes what the medicine can do for you.

The reasons people struggle are practical and predictable. Digestive effects appear while the dose is being raised. Weight loss can slow down, which feels discouraging even when the plan is working. Storage, travel and weekly habits take some learning. Cost can weigh on a long-term plan. None of these means treatment has failed, and each has a sensible response.

02 · What to do next

The decisions most people actually face

Most readers are weighing one of three decisions: how to cope with side effects without quitting, whether a slower patch means the medicine is not working, and whether the long-term cost and effort are sustainable. The right first step for all three is the same: tell your prescriber what is happening. They can discuss how quickly you move up, review your other medicines or advise on your dose. Please do not change your dose on your own.

If you are early in treatment, build a routine before you worry about results. Choose a day, set a reminder, and keep your pens stored properly. Our guide to building a weekly GLP-1 routine covers the practical side in more detail.

03 · Where to go from here

If you are already treated elsewhere or thinking of starting

If you are considering treatment, our weight loss clinic explains how a free online consultation works, and a GPhC-registered prescriber decides whether treatment is suitable. If you already take a GLP-1 medicine and are struggling, speak to whoever prescribes it before making any changes. Ongoing support, including monthly reviews and side-effect support, is part of how we work.

When cost is part of your adherence worry, plan ahead. The standard price of the Mounjaro 2.5mg starter pen is £169.99 per month, and if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. You can see all current doses on the Mounjaro pen page, with prices checked 10 October 2026. Knowing the whole picture before you begin makes it far easier to stay the course.

How long you stay on treatment depends on your health, your goals and how you respond, and it is a decision to make with your prescriber.

Related guide: Glp 1 kvapky uzivanie.

04 · Why people stop

Why people stop GLP-1 treatment

People stop GLP-1 treatment for a handful of repeating reasons: digestive side effects, impatience when progress slows, the effort of the dose-step schedule, practical hassle and cost. Understanding which one is yours is the key to fixing it, because each has a different remedy.

Side effects come first for many. Nausea, diarrhoea, vomiting, constipation and abdominal discomfort are the most commonly reported effects, and they cluster around starting treatment and moving up a dose.¹³ If you meet them during a rough week, quitting can feel like the only exit. In reality your prescriber has other options, including discussing how quickly you move up.

The second reason is expectation. Marketing and social media make fast results sound routine. Trial averages are not individual predictions, and progress is rarely a straight line. When a plateau arrives, people wrongly conclude the medicine has stopped working and stop it. A better response is a review of your food, activity, sleep and dose with your prescriber.

Third is the weekly habit itself. A once-weekly injection sounds simple, but life gets in the way: holidays, shift work, a missed reminder, a pen left in the wrong place. A few simple systems fix most of this.

Fourth is cost and access. Long-term treatment is an ongoing monthly expense for private patients, and NHS access is still being phased in. Planning for the full journey before you start, rather than discovering the cost midway, protects against dropping out for financial reasons.

Fifth is the emotional side: stigma, comparisons with other people, and fear of what others think. Treatment is a medical decision made with a clinician, and you are entitled to keep it private. If it affects your mood, tell your prescriber.

Finally, some people stop because they feel better and assume the job is done. Whether to continue is a medical decision with your prescriber, not something to guess at.

The consistent message is that stopping suddenly, without a conversation, is rarely the best option. A short call or message to your prescriber costs nothing and often resolves the problem that was about to end your treatment.

05 · Managing side effects

Managing side effects so you can keep going

Most side effects are digestive and short-lived, which is why managing them well is the single biggest adherence tool. Like all medicines, Mounjaro can cause side effects, and most are digestive. The most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹³ Common effects (up to 1 in 10) include indigestion, reduced appetite, dizziness, reflux, burping, hair shedding and injection-site reactions. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.

Knowing the pattern helps you ride it out. If you are about to increase your dose and remember that the last increase was uncomfortable for a short while, you can plan lighter meals and a quieter week. You can also tell your prescriber in advance. For more on what to expect, our guide to GLP-1 side effects and how to manage them goes into more depth.

Because the medicine slows how quickly the stomach empties, large or rich meals can feel unpleasant. Smaller portions and eating slowly are sensible everyday habits, and your prescriber or pharmacist can suggest more. Do not start over-the-counter remedies or supplements without checking with a pharmacist first, since they can interact with how you feel or with other medicines.

What about bowels? Constipation and diarrhoea are both on the common list. If either becomes severe or does not settle, speak to your prescriber instead of waiting it out.

Serious side effects: when to get help immediately

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion), as your prescriber may need to adjust those medicines.

Staying on treatment is never worth ignoring these warning signs. If you have chest pain, a racing heart or you faint, get medical help straight away. For any other new symptom that worries you, speak to your prescriber or pharmacist, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹

A symptom that is not on the patient leaflet list is not a listed side effect; tell your prescriber about any new or lasting symptom.

06 · Dose steps and adherence

Dose steps: how the ladder affects staying on track

Mounjaro treatment moves gradually, and understanding the ladder makes it easier to stick with. The pen comes in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Treatment begins at the lowest strength, and people spend at least 4 weeks on each dose, depending on how you respond. Your prescriber decides when to move up and which dose you settle on.

The point of the ladder is to let the body adjust, which is why digestive effects tend to appear around the steps. It is not a race and it does not stop at any particular strength. Some people settle at a lower dose, others continue upward. Both are normal, and the choice sits with your prescriber based on your response and how you tolerate it.

From an adherence viewpoint, the ladder has two useful implications. First, side effects are most predictable around a dose increase, so you can plan for them. Second, each step is a natural point for a check-in, which is why ongoing monthly reviews matter.

Never take extra doses, shorten the gap between doses or use a pen differently from how the leaflet describes. Taking medicine in unlicensed ways is not something we advise, and anything that worries you about your dose should go to your prescriber.

Wegovy has its own ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, stepping up after 4 weeks on each of the first four doses, with the 2.4mg maintenance dose starting from week 17. Each medicine has its own schedule and licensed maintenance dose, and a prescriber will explain which fits your circumstances. You can read about the Wegovy pen on its product page.

If you miss a dose or are unsure about timing, do not guess. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time; if more than 4 days have passed, skip it and take the next one on your normal day — never take two doses within 3 days of each other. Our team is available Monday to Friday for questions about your order and treatment.

07 · Building a routine

Building a routine that lasts

A routine is the least glamorous and most effective adherence tool. Pick a day each week, pair the injection with something you already do, and set a recurring reminder. The more automatic it feels, the less willpower it takes. Our dedicated guide to a weekly GLP-1 routine expands on this, but the essentials are simple.

Storage is the part people most often get wrong. Keep Mounjaro pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, which is useful for short trips, and must then be thrown away. Keep the pen cap on to protect it from light, and never use a pen that has been frozen.¹

Travel is where routines wobble. Plan the trip around the pen: confirm that you can keep it cool and capped, pack it in hand luggage rather than a hold where temperatures vary, and carry the dispensing label. A small accessory purchase such as an insulated bag can help, but keep the pen away from direct contact with ice packs so it is not frozen.

Tracking helps too. GLPTrackr is our free companion app for tracking a GLP-1 journey, available on iOS and Android. Logging injection days, symptoms and how you feel gives you better information to bring to your monthly review, and it makes patterns easier to spot.

Think about what trips you up personally. If it is forgetting, use alarms and a visible note. If it is nervousness about injecting, needles, a sharps bin and injection guidance are included with every order, and the pen leaflet shows the steps. If it is irregular work patterns, choose the day with the fewest disruptions and tell your prescriber if your schedule changes.

When you reorder, plan ahead. Repeat orders re-check suitability and there is no auto-shipping, so you decide when to order. Order before you run low, because a gap in supply is one of the avoidable reasons people drift off treatment. Same-day dispatch applies when ordered by 3pm, with free next-day tracked delivery in temperature-controlled packaging.

If a routine breaks down, do not abandon the plan. Pick it back up sensibly and ask for advice on timing if a dose has been missed. Small slips do not end a treatment journey, and talking about them early keeps you on course.

08 · Other medicines and contraception

Other medicines, contraception and staying safe

Staying on treatment safely means telling your prescriber about everything else you take. The medicine slows stomach emptying, which can affect how some oral medicines are absorbed, and it can change how much of other treatments you need.

The best-known example is the oral contraceptive pill. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. This applies to the pill only; implants, coils and injections are unaffected.⁷ Because dose increases keep happening during titration, this is easy to forget, so build it into your routine.

Diabetes medicines are the other key group. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar, such as shakiness, sweating and confusion, as your prescriber may need to adjust those medicines. That is a reason to be open with your prescriber, not a reason to stop either treatment on your own.

Alcohol, supplements and over-the-counter products deserve the same care. Check with a pharmacist before adding anything new, particularly products that claim to act like a GLP-1 medicine. Low-cost supplements are available without assessment, offer no clinical oversight, and are not a substitute for a licensed treatment. Dosing is not standardised for them.

Who should not take Mounjaro? You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. A GPhC-registered prescriber reviews your health history, current medicines and circumstances before any prescription is issued; payment is taken when you place the order, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Please answer the questionnaire fully and honestly, since that protects you.

If your health changes while on treatment, such as a new diagnosis, a new medicine or a hospital stay, tell your prescriber. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. If you are having an operation or procedure under sedation or general anaesthetic, tell the surgical team you take Mounjaro — because it slows stomach emptying, they may give specific fasting or medication-pause instructions before the procedure.

And the same urgent signals apply throughout: severe, persistent stomach pain that may spread to your back, pain in the upper right abdomen with fever or yellowing of the skin or eyes, or signs of a severe allergic reaction need immediate medical help. Adherence never outranks safety.

If you would like an overview of what a prescriber looks at, our guide to getting a Mounjaro GLP-1 online prescription describes the process.

09 · Expectations and plateaus

Realistic expectations and plateaus

Unrealistic expectations are a major quiet driver of stopping, so it helps to know what trial figures do and do not tell you. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Note the trial length: the results reflect more than a year of treatment, not a few weeks. That matters for adherence, because a person who judges the medicine after a short time may stop before the effect has had time to build.

As a worked example only, for someone starting at 100 kg, 20.9% is about 21 kg. That is an average from a trial, not a forecast of what you will see, and your own result may be higher or lower.

What about plateaus? Progress slows for many people at some point. A plateau does not automatically mean the medicine has failed. Appetite, food habits, sleep, activity, stress and dose all play a part, and measures other than the scale, such as how clothes fit, energy and health markers, tell you something too. Raise the plateau at your review instead of stopping, so your prescriber can look at the whole picture.

Equally, trial participants were supported and monitored. Real life brings holidays, illness and stress. Adjusting your expectations to match is not pessimism; it protects you from the disappointment that leads to dropping out.

Finally, a note on comparisons. Do not set your progress beside another person's. The first large head-to-head trial of tirzepatide and semaglutide for weight loss is SURMOUNT-5, and your prescriber can explain what it means for you. Your own plan, set with a clinician, is the one that counts.

10 · Cost and access over time

Cost, NHS access and long-term planning

Long-term access is an adherence issue in its own right, so it is worth thinking through NHS and private routes before you start. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions. Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁴⁶

If you pay privately, plan for the full journey. The standard price of the 2.5mg pen is £169.99 per month, and if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, all at standard prices. A new customer's first order is £40 less and every later order £25 less. Other maintenance doses are priced per month: £279.99 at 7.5mg, £290.99 at 10mg and £319.99 at 12.5mg. Prices were checked 10 October 2026.

Having that picture early helps you decide whether the plan is sustainable. Part of good adherence is not starting something you cannot comfortably continue. If your budget is tight, say so at consultation and ask what is realistic. Payment options include Visa, Mastercard, Klarna and pay-monthly options, and there are no subscriptions, so you are never locked in.

How we support continuity: our consultation is free and the price shown is the price paid, with no hidden fees. Treatment is supplied as official LillyDirect supply, which is Mounjaro direct from Eli Lilly's UK distribution, with genuine KwikPens and all six doses stocked. Delivery is free, next-day and tracked in discreet, temperature-controlled packaging. Ongoing monthly reviews, dose-titration and follow-up assessments are part of the aftercare.

If you are weighing NHS and private routes, our weight loss clinic page lays out how our service works. You may also want to look at oral GLP-1 options, because some people find a tablet easier to fit into daily life. Tablets have their own instructions and eligibility, and prices are on the relevant product pages.

Whatever route you take, keep your prescriber informed. A medicine that is available and reviewed regularly is easier to stay on.

11 · Stopping and restarting

Stopping, pausing and restarting safely

Whether you can ever stop is a decision to make with your prescriber, and the sensible answer is never to stop abruptly without that conversation. People stop for many reasons: they reach a goal, they have a side effect, they face a cost, or life changes. Each reason deserves a plan.

What happens physically when you stop? Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ That means the effects do not vanish overnight, but it also means a pause is not a reset. If you plan to restart after a gap, speak to your prescriber, who will advise on the dose to restart on.

If side effects are the reason you want to stop, tell your prescriber first. They may suggest a different approach. If cost is the reason, discuss alternatives before you quit. If you are pregnant or planning a pregnancy, stop the medicine and tell your prescriber promptly; Mounjaro must not be used during pregnancy and should be stopped at least one month before trying to conceive.

Plan what comes next. Stopping tirzepatide often leads to weight regain. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber. Medicines are used alongside a reduced-calorie diet and increased physical activity, and habits you build during treatment are the part you keep. Many people find that continuing regular meals, movement and monthly check-ins matters as much as the injection itself. Ask your prescriber what a sensible plan looks like for you if you do come off treatment.

Do you have to stay on a GLP-1 medicine forever? There is no universal answer, and nobody can responsibly give one without knowing your health. The decision depends on why you started, how you responded, your health conditions and what you and your prescriber agree. Treat it as an ongoing conversation, not a one-off choice.

Switching products is a different path. Some people move between a GLP-1 injection, another injection or a tablet, depending on tolerability and preference. Never swap on your own; your prescriber will explain the doses and timing for the new medicine. And if you ever feel that your plan is no longer working for you, a call to our support team on 0333 207 0413 or an email to support@everydaymeds.co.uk is a good first step.

Finally, keep unused pens in the fridge until first use, and throw away any in-use pen after 30 days not above 30°C, or sooner if it has been above 30°C. Return to your prescriber for advice instead of using old pens after a long break.